Name: PENTIXAPHARM HOLDING AG (PTP) Stock
Brand: PENTIXAPHARM HOLDING AG
Rating: 3.5 (3 reviews)

Question 1

What does PENTIXAPHARM HOLDING AG do?

Accepted Answer

Pentixapharm Holding AG engages in the development of radiopharmaceutical approaches for diagnostic and therapeutic programs in a number of hematological and solid cancers, as well as cardiovascular, endocrine, and inflammatory diseases. The company is headquartered in Berlin, Berlin and currently employs 64 full-time employees. The company went IPO on 2024-10-03. The firm focuses on the development of radiopharmaceuticals for various therapeutic areas, as well as for the diagnosis and therapy (theranostics) of blood cancer and others. The company is also engaged in holding activities and is also involved in the research and development of drugs for hematological and solid cancers, as well as cardiovascular, endocrine and inflammatory diseases.

Question 2

What is the current price of PTP stock?

Accepted Answer

The current stock price of PTP.DE is 1.5 EUR. The price decreased by -2.6% in the last trading session.

Question 3

Does PENTIXAPHARM HOLDING AG pay dividends?

Accepted Answer

PTP.DE does not pay a dividend.

Question 4

What is the ChartMill rating of PENTIXAPHARM HOLDING AG stock?

Accepted Answer

PTP.DE has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.

Question 5

Can you provide the PE ratio for PTP stock?

Accepted Answer

PENTIXAPHARM HOLDING AG (PTP.DE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.86).

Question 6

What is the ownership structure of PENTIXAPHARM HOLDING AG (PTP.DE)?

Accepted Answer

You can find the ownership structure of PENTIXAPHARM HOLDING AG (PTP.DE) on the Ownership tab.

PENTIXAPHARM HOLDING AG (PTP.DE) Stock Price, Forecast & Analysis

PTP.DE Latest News, Press Relases and Analysis